Why It Matters

A patient in his early 30s recently asked me: “Do I need to stop my ADHD medication to have a child?”

He and his partner had just started trying to conceive, and he’d come across conflicting information online. It’s a fair question. Medications like Adderall and Ritalin are widely used—but their effects on male fertility aren’t well understood.

And the answer, at least right now, isn’t straightforward.

What the Research Shows

Semen parameters: conflicting data

Some studies show lower sperm count, motility, or semen volume with stimulant use
Others show no effect—or even improved parameters
overall, there’s no consistent signal.

Testosterone and testicular function

One large study found a higher rate of “testicular hypofunction” diagnoses with long-term stimulant use
Shorter-term studies show no meaningful hormonal changes
overall: possible signal, but far from definitive

Animal data

Stimulants (e.g., lisdexamfetamine) can reduce sperm quality and testosterone in animal models
These effects appear reversible after stopping

Key Takeaways

Evidence is limited and inconsistent
Some data suggest possible effects on sperm or testicular function
Other studies show no effect
There is no clear causal conclusion in humans
No meaningful comparison between agents: we can’t say whether amphetamines vs methylphenidate differ in fertility risk
Most importantly: these studies look at sperm metrics—not actual fertility
There are no studies linking paternal stimulant use to conception rates or offspring outcomes

My Take

Two things can be true at once:

Some studies show changes in sperm parameters
Those changes may not meaningfully affect real-world fertility

Semen analyses are imperfect. There’s a lot of overlap between fertile and infertile men, and small shifts in numbers don’t necessarily translate into difficulty conceiving.

So the real question isn’t: “Do stimulants change sperm numbers?”.

The question to ask is: “Do they actually affect the ability to have a child?” And right now—we simply don’t know; this hasn’t been directly studied. This ends up being a risk vs function tradeoff. For many patients, untreated ADHD has real consequences—and stopping medication isn’t trivial.

If a couple is having diffculty conceiving, then it’s best to start with a referral to a Fertility Specialist for a full workup. If there are no findings to explain their challenges, and there is some suspicion regarding the contribution of their ADHD treatment to the problem, then a careful and nuanced discussion is warranted.

If you're seeking evaluation or treatment for adult ADHD in the Bay Area, learn more about our approach here.

Sources

Pham MN, Hudnall MT, Fantus RJ, et al. The Adverse Association Between Stimulant Use for Attention Deficit Hyperactivity Disorder (ADHD) and Semen Parameters. Andrologia. 2022;54(2):e14315. doi:10.1111/and.14315

Aliakbari F, Hosseini J, Hashemi R, et al. Relationship Between Long-Term Use of Ritalin and Semen Parameters in Patients Referred to Psychiatric Centres. Andrologia. 2022;54(11):e14594. doi:10.1111/and.14594

Shalev H, Mizrakli Y, Zeadna A, et al. Does Methylphenidate Use Affect Sperm Parameters in Patients Undergoing Infertility Investigation? A Retrospective Analysis of 9769 Semen Samples. Archives of Gynecology and Obstetrics. 2021;304(2):539-546. doi:10.1007/s00404-020-05938-z

Ostdiek-Wille GP, Bavitz KC, Kohn TP, Deibert CM. Attention-Deficit Hyperactivity Disorder Medication Use Is Associated With Testosterone Hypofunction-Results From a National Claims Database Analysis. International Journal of Impotence Research. 2024;36(4):403-407. doi:10.1038/s41443-023-00805-2

Wang LJ, Lee SY, Chou WJ, et al. Testicular Function After Long-Term Methylphenidate Treatment in Boys With Attention-Deficit/Hyperactivity Disorder.Journal of Child and Adolescent Psychopharmacology. 2019;29(6):433-438. doi:10.1089/cap.2018.0126

Wang LJ, Huang YH, Chou WJ, et al. Potential Disturbance of Methylphenidate of Gonadal Hormones or Pubescent Development in Patients With Attention-Deficit/Hyperactivity Disorder: A Twelve-Month Follow-Up Study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2021;108:110181. doi:10.1016/j.pnpbp.2020.110181